-
公开(公告)号:EP2081598A2
公开(公告)日:2009-07-29
申请号:EP07821457.4
申请日:2007-10-17
发明人: VAN'T KLOOSTER, Gerben Albert Eleutherius , DE KOCK, Herman Augustinus , RABOISSON, Pierre Jean-Marie Bernard , VAN DEN EYNDE, Christel Florentina E.
IPC分类号: A61K45/06 , A61K38/04 , A61K31/4709 , A61K31/428 , A61P31/12
CPC分类号: A61K31/4709 , A61K31/428 , A61K38/04 , A61K45/06 , A61K2300/00
摘要: The present invention relates to the combination comprising an HCV NS3/4a protease inhibitor and a compound of formula (II). The combination is useful to improve the bioavailability of the HCV NS3/4a protease inhibitor. As such, the combination is useful for treating conditions associated with the Hepatitis C virus in patients. Pharmaceutical compositions and kits comprising this combination, and processes for preparing the combination and the pharmaceutical formulations are also provided.